Peter Thiel is a key investor in Nucleus Genomics, which screens IVF blastocysts for genetic diseases, height, intelligence, and other factors, which allows prospective parents to pick and choose specific traits for their babies. Some institutions say this process is moving too fast.

What is certain is that the economics, thirty thousand dollars per IVF screening of 40 fertilized eggs, will favor the wealthy.
Being voluntary distinguishes this from the early attempts of ignorant eugenics.

The future is brave and has more certainty for the wealthy.

https://mynucleus.com/